ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1857

Role of autoantigen-specific reactivity in the pathogenesis of murine interstitial lung disease model with anti-MDA5 antibody mouse model

Atsubumi Ogawa1, Ran Nakashima2, Tsuneyasu Yoshida3, Keisuke Hirobe1, Yasuhiro Nohda1, Tsuneo Sasai1, Mirei Shirakashi2, Ryosuke Hiwa1, Hideaki Tsuji1, Shuji Akizuki2, Hajime Yoshifuji2, Kosaku Murakami4, Norimichi Nomura5, Atsuyasu Sato6, Motomu Hashimoto7 and Akio Morinobu8, 1Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 2Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan, 3Division of Clinical Immunology and Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 4Division of Clinical Immunology and Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan, 5Department of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 6Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 7Department of Clinical Immunology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Sakyo-ku, Japan, 8Kyoto University, Kyoto, Kyoto, Japan

Meeting: ACR Convergence 2025

Keywords: dermatomyositis, Mouse Models, Other

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1855–1876) Systemic Sclerosis & Related Disorders – Basic Science Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Anti-Melanoma differentiation-associated gene 5-positive dermatomyositis (MDA5-DM) is often complicated by rapidly progressive interstitial lung disease (RP-ILD) and has a poor prognosis. Although there has been one report on this disease mouse model, the role of autoantigen-specific reactivity, especially anti-MDA5 antibody itself, on the pathogenesis of the disease has never been elucidated. In this study, we established a new mouse model of MDA5-DM-ILD and investigated the meanings of autoreactivity to MDA5 in the pathogenesis of the disease.

Methods: C57BL/6J wild-type mice were immunized with complete Freund’s adjuvant (CFA) and recombinant human MDA5 protein purified from baculovirus-insect cell system 6 times once a week, and polyinosinic-polycytidylic acid (poly I:C) was administered intratracheally 16 times over a 4-week period, starting from the 3rd week. The production of anti-mouse MDA5 antibodies was confirmed by immunoprecipitation. The area of cell infiltration in lung was quantitatively evaluated using an all-in-one fluorescence microscope (BZ-X810), the cell ratio was evaluated by flow cytometry, and interferon-stimulated gene (ISG) was evaluated by RT-PCR. In addition, we observed whether the lung infiltrating cells were reacted with MDA5 protein and releasing cytokines and granzyme B. After then, CD4(+) T cells and B cells were sorted and co-cultured, and IFN-γ production was confirmed by adding MDA5 protein. Furthermore, anti-human MDA5 monoclonal mouse antibodies were transferred intraperitoneally to C57BL/6J wild-type mice 5 times once a week, and poly I:C was administered intratracheally 16 times over a 4-week period, and the area of cell infiltration in lung tissue was quantitatively evaluated.

Results: We confirmed the production of anti-mouse MDA5 antibodies in immunized mice. The MDA5-immunized/poly I:C mice showed larger cellular infiltration area of the lungs (p< 0.01, Figure1) and lower survival (p< 0.05) compared to CFA only immunized/poly I:C mice. ISG15 expression in lung tissue was increased. In vitro cytokine releasing assay using MDA5 protein revealed that lung-infiltrating cells of MDA5-immunized/poly I:C mice produced significantly more IFN-γ, IL-15, and granzyme B than control mice (p< 0.05, Figure2), which can be observed even after purification of infiltrating B cells and CD4(+) Tcells.The area of pneumonia in the mice injected with the monoclonal antibody was different from that in the mice injected with normal IgG, with dominant cellular infiltration just below the pleura, which was similar to the initial development of ILD in MDA5-DM patients (Figure3).

Conclusion: Infiltration of MDA5-specific T/B cells in the lungs as well as anti-MDA5 antibody itself may play a pivotal role for lung injury in MDA5-DM.

Supporting image 1Figure1. Overview of MDA5-immunized mice model

Supporting image 2Figure 2. The release of IFN-γ, IL-15, and Granzyme B by lung-infiltrating cells

Supporting image 3Figure 3. Overview of anti-MDA5 monoclonal antibody transferred mice


Disclosures: A. Ogawa: None; R. Nakashima: None; T. Yoshida: None; K. Hirobe: TAISHO PHARMACEUTICAL HOLDINGS CO., LTD., 6; Y. Nohda: None; T. Sasai: None; M. Shirakashi: None; R. Hiwa: None; H. Tsuji: None; S. Akizuki: None; H. Yoshifuji: AbbVie/Abbott, 6, Chugai, 6, Janssen, 6; K. Murakami: None; N. Nomura: None; A. Sato: None; M. Hashimoto: None; A. Morinobu: None.

To cite this abstract in AMA style:

Ogawa A, Nakashima R, Yoshida T, Hirobe K, Nohda Y, Sasai T, Shirakashi M, Hiwa R, Tsuji H, Akizuki S, Yoshifuji H, Murakami K, Nomura N, Sato A, Hashimoto M, Morinobu A. Role of autoantigen-specific reactivity in the pathogenesis of murine interstitial lung disease model with anti-MDA5 antibody mouse model [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/role-of-autoantigen-specific-reactivity-in-the-pathogenesis-of-murine-interstitial-lung-disease-model-with-anti-mda5-antibody-mouse-model/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/role-of-autoantigen-specific-reactivity-in-the-pathogenesis-of-murine-interstitial-lung-disease-model-with-anti-mda5-antibody-mouse-model/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology